Does a predictive model identify patients most likely to have inadequate bowel preparation for colonoscopy?
We identified factors associated with inadequate bowel preparation for colonoscopy and used these to build an accurate predictive model.
Selective COX-2 inhibition, using the well-tolerated and commercially available Rofecoxib (VIOXX) and specific COX 1 and 2 inhibitors, reduced the growth of human bladder cancer in vitro by apoptotic mechanisms. Further in vivo and human studies are warranted to evaluate the safety and clinical utility of this agent in patients with bladder cancer.